What is Tirzepatide?
Tirzepatide is a dual agonist that activates two gut-hormone receptors, GIP and GLP-1. It is FDA-approved and sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.
Zepbound has also been approved for moderate-to-severe obstructive sleep apnea in adults with obesity.
How it is thought to work
By acting on both the GIP and GLP-1 receptors, tirzepatide reduces appetite, slows stomach emptying, and improves the body's insulin response. The dual mechanism is thought to contribute to the strong results seen in trials.
What the research shows
In the SURMOUNT and SURPASS trial programs, tirzepatide produced substantial weight loss and strong blood-sugar control. Results in these trials were among the largest reported for a medication of this class, used alongside lifestyle change.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Approved uses
- Chronic weight management in eligible adults (per approved use)
- Blood-sugar control in type 2 diabetes
- Obstructive sleep apnea in eligible adults with obesity
Availability
Tirzepatide is FDA-approved and available now by prescription. It does not depend on the 2026 peptide review.
As with other GLP-1 medications, the standard route is the branded approved product. Imports of infringing tirzepatide have been blocked by a trade exclusion order, so providers direct patients to legitimate supply.
How to access Tirzepatide legitimately
A licensed provider evaluates your eligibility and prescribes the branded product through a licensed pharmacy, typically titrating the dose upward over time.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
Is tirzepatide stronger than semaglutide? Trials suggest tirzepatide can produce larger average weight loss, but the right choice depends on your health profile and is a decision for you and your provider.
Is it available now? Yes. It is FDA-approved and prescribable today for patients who meet clinical criteria.
Does PeptideForward sell it? No. We connect you with licensed providers and never sell or supply any medication.